Lee Ainslie - Maverick Capital
Holding/activity history for TG Therapeutics Inc. (TGTX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q1 | 0 | 0 | Sell 100.00% | 1.24 | |
| 2022 Q4 | 4,318,700 | 1.24 | Reduce 43.93% | 0.97 | $11.83 |
| 2022 Q3 | 7,701,870 | 1.03 | Add 14.14% | 0.13 | $5.92 |
| 2022 Q2 | 6,747,549 | 0.72 | Add 1.05% | 0.01 | $4.25 |
| 2022 Q1 | 6,677,726 | 1.14 | Add 10.65% | 0.11 | $9.51 |
| 2021 Q4 | 6,034,875 | 1.39 | Add 83.07% | 0.63 | $19.00 |
| 2021 Q3 | 3,296,451 | 1.21 | Add 16.85% | 0.17 | $33.28 |
| 2021 Q2 | 2,821,079 | 1.03 | Reduce 5.05% | 0.05 | $38.79 |
| 2021 Q1 | 2,971,136 | 1.34 | Reduce 7.21% | 0.10 | $48.20 |
| 2020 Q4 | 3,202,061 | 2.67 | Reduce 27.10% | 0.99 | $52.02 |
| 2020 Q3 | 4,392,196 | 2.18 | Add 3277.60% | 2.12 | $26.76 |
| 2020 Q2 | 130,039 | 0.05 | Buy | 0.05 | $19.48 |